The proposed bill, known as the "Doug Cameron Act," aims to establish a moratorium on the use of human gene therapy products in Idaho, particularly for immunizations against infectious diseases. This legislation is motivated by the intent to protect the health and safety of Idaho citizens, following the severe injury of Doug Cameron, an Idaho rancher, after receiving a genetic immunization. The bill defines "human gene therapy product" and outlines the types of products that fall under this category, including nucleic acids, genetically modified microorganisms, engineered nucleases, and ex vivo genetically modified human cells.

The moratorium will prohibit the administration of these gene therapy products for infectious disease indications until July 1, 2035, with the possibility of legislative review based on safety data. However, the provisions of the bill will not apply to human gene therapy products used for the treatment of cancer or genetic disorders. The act is set to take effect on July 1, 2025, following the declaration of an emergency.